Pharmaceutical

Vendor:

First CVE: Apr 20, 2006 · Active for 20 years

2

Total CVEs

More Total CVEs than 49% of tracked products

2.0

Avg CVEs / Year

Higher CVE frequency than 60% of tracked products

10.0

Avg CVSS

Higher Avg CVSS than 99% of tracked products

0.0%

KEV Rate

Bottom 1%

Trends Over Time

The number and severity of CVEs published that impact Pharmaceutical over time

Volume of CVEsAvg CVSS Base Score

First CVE

Apr 20, 2006

20 years ago

Most Recent CVE

Oct 18, 2006

7,219 days ago

CVE Severity & Scoring

Pharmaceutical2 CVEs

100%

All CVEs352,294 CVEs

45%

40%

11%

High

Attack Vector

Local0 (0.0%)

Network0 (0.0%)

Unknown2 (100.0%)

Physical0 (0.0%)

Adjacent Network0 (0.0%)

Attack Complexity

Low0 (0.0%)

High0 (0.0%)

Unknown2 (100.0%)

User Interaction

None0 (0.0%)

Unknown2 (100.0%)

Required0 (0.0%)

Privileges Required

Low0 (0.0%)

High0 (0.0%)

None0 (0.0%)

Unknown2 (100.0%)

Top CVEs

Signals from CVEs in this product scope (2 CVEs).

2 CVEs · Highest risk first

CVE	Published	CVSS	Risk	KEV	Exploit
CVE-2006-5374HIGH Unspecified vulnerability in Oracle Pharmaceutical Applications 4.5.1 has unknown impact and remote authenticated attack vectors, aka Vuln# PHAR01.	Oct 18, 2006	10.0	26	NO	NO
CVE-2006-1884HIGH Unspecified vulnerability in the Oracle Thesaurus Management System component in Oracle E-Business Suite and OPA 4.5.2 Applications has unknown impact and attack vectors, aka Vuln#	Apr 20, 2006	10.0	26	NO	NO

View all 2 CVEs →

Exploit Exposure

Signals from CVEs in this product scope (2 CVEs).

CISA KEV

0 CVEs

0.0% of CVEs· Bottom 1%

Metasploit

0 CVEs

0.0% of CVEs· Bottom 1%

Nuclei

0 CVEs

0.0% of CVEs· Bottom 1%

ExploitDB

0 CVEs

0.0% of CVEs· Bottom 1%

Social Chatter

Signals from CVEs in this product scope (2 CVEs).

Media Mentions

Signals from CVEs in this product scope (2 CVEs).

Top CNAs Publishing CVEs For Pharmaceutical

Versions

Version	CVE Count	Avg CVSS	Avg EPSS
4.5.2	1	10.0	3.8%
4.5.1	2	10.0	4.0%
4.5.0	1	10.0	3.8%